Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mindaugas Jurgutis
Observed name:
Jurgutis, Mindaugas
Institution:
Republic Klaipeda Hospital
Observed institutions:
Medical University of Lublin,
Wroclaw Medical University,
Republic Klaipeda Hospital
OpenAlex ID:
A5083589098
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
2015
·
Animesh Pardanani
, Claire Harrison
, et al.
·
JAMA Oncology
·
485
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
2018
·
Mohamad Mohty
, Mohamad Mohty
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
82
Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis
2021
·
Animesh Pardanani
, Ayalew Tefferi
, et al.
·
British Journal of Haematology
·
70
PDF
Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia
2011
·
Regina Pileckyte
, Mindaugas Jurgutis
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
33
Results Of a Randomized, Double-Blind, Placebo-Controlled Phase III Study (JAKARTA) Of The JAK2-Selective Inhibitor Fedratinib (SAR302503) In Patients With Myelofibrosis (MF)
2013
·
Animesh Pardanani
, Claire N Harrison
, et al.
·
Blood
·
32
Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013
2016
·
Tumas Beinortas
, Ilma Tavorienė
, et al.
·
BMC Cancer
·
24
PDF
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM ‐ ET 2·0 trial
2019
·
Heinz Gisslinger
, Veronika Buxhofer‐Ausch
, et al.
·
British Journal of Haematology
·
7
Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia
2008
·
Laimonas Griskevicius
, Rokas Stulpinas
, et al.
·
Leukemia Research
·
4
Symptom Burden and Health-Related Quality Of Life (HRQoL) In Patients With Myelofibrosis (MF) Treated With Fedratinib (SAR302503) In a Phase III Study (JAKARTA)
2013
·
Ruben A. Mesa
, Jorge E. Cortes
, et al.
·
Blood
·
3
Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF): Updated Results from the Randomized, Placebo-Controlled, Phase III JAKARTA Trial
2020
·
Animesh Pardanani
, Ayalew Tefferi
, et al.
·
Blood
·
2
Phase 3 trial team-ET in 106 high-risk Essential Thrombocythemia patients, demonstrating non-inferiority of anathromb, a novel, extended-release anagrelide formulation, to the licensed comparator
2016
·
Heinz Gisslinger
, Atanas Radinoff
, et al.
·
Lithuanian University of Health Sciences
Additional file 1: of Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013
2016
·
Beinortas, Tumas
, Tavorienė, Ilma
, et al.
·
Figshare
Hemofilijos diagnostikos ir gydymo metodika : TLK10-D66-67
2013
·
Neringa Gailiūtė
, Romualdas Jurgutis
, et al.
·
Lithuanian University of Health Sciences
The Baltic lymphoma project: report on lymphoma incidence and survival in Lithuania
2008
·
Griškevičius, Laimonas
, Daubarienė, Jūratė
, et al.
·
Lithuanian University of Health Sciences
Difuzine didelių B ląstelių skrandžio limfoma sergančių ligonių, gydytų chirurgiškai ir tęsiant adjuvantinę chemoterapiją, išgyvenamumas, palyginus su ligoniais, kuriems taikyta tik chemoterapija: retrospektyvi studija
2008
·
Elsakov, Pavel
, Kurtinaitis, Juozas
, et al.
·
Lithuanian University of Health Sciences
The outcome of chemo-immunotherapy for Burkitt lymphoma in Lithuania
2008
·
Sonata Šaulytė-Trakymienė
, Rokas Stulpinas
, et al.
·
Lithuanian University of Health Sciences
Lėtinės ligos „transplantatas prieš šeimininką“ pasireiškimas nefroziniu sindromu po kraujo kamieninių ląstelių persodinimo
2007
·
Priluckienė, Janina
, Kriukelytė, Indrė
, et al.
·
Laba (Lietuvos akademinių bibliotekų direktorių asociacija)
[Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
2007
·
Janina Priluckiene
, Indre Kriukelyte
, et al.
·
PubMed
Šeimos medicinos pagrindai : [vadovėlis rekomenduojamas studentams medikams, šeimos medicinos rezidentams, persikvalifikuojantiems į šeimos gydytojus ir bendrosios praktikos gydytojams]
2003
·
Rita Armonaitė
, Aldona Vitalija Baltrėnaitė
, et al.
·
Lithuanian University of Health Sciences
Šeimos medicinos pagrindai : [vadovėlis studentams medikams ir gydytojams rezidentams rengti, taip pat gydytojams, persikvalifikuojantiems į šeimos gydytojus]
2000
·
Armonaitė, Rita
, Baltrėnaitė, Aldona Vitalija
, et al.
·
Lithuanian University of Health Sciences
Show more works
View as search
Works count:
23
Citation count:
850
H-index:
7
I10-index:
7
Year
Topic
Type
